Core Viewpoint - Jin Hai Medical Technology (02225) experienced a significant stock price increase, rising over 15% during trading and currently up 5.04% at HKD 1.25, with a trading volume of HKD 12.1974 million [1] Group 1: Company Developments - Jin Hai Medical announced a collaboration with Medtronic China to unveil a new navigational spinal endoscopy innovation during the 8th China International Import Expo, scheduled from November 5 to 10 in Shanghai [1] - The new technology is expected to enhance precision and intelligence in spinal surgeries, reducing the learning curve for clinicians in spinal endoscopy techniques and promoting more efficient and widespread clinical applications in the future [1] Group 2: Industry Context - Medtronic's primary business includes the development, manufacturing, distribution, and sales of medical therapies and services in cardiovascular disease, neuroscience, surgical technologies, and diabetes [1] - Medtronic has established production bases in Shanghai, Changzhou, and Chengdu, and has participated in the China International Import Expo for seven consecutive years since its inception in 2018, leveraging the event's influence to showcase and accelerate the application of its latest innovative medical technologies and products [1]
今海医疗科技盘中涨超15% 今海医疗携手美敦力亮相进博会 发布导航下脊柱内镜创新技术